425: Strive & Semler Scientific Merger: Cautionary Outlook

Strive, Inc. reposted a communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. filed a Form 425 communication on December 4, 2025, regarding its proposed business combination with Semler Scientific, Inc.
• The communication, reposted by Ben Werkman, Chief Investment Officer of Strive, Inc., primarily serves as a cautionary statement concerning forward-looking information related to the merger.
• It highlights inherent risks and uncertainties that could cause actual results to differ materially from anticipated outcomes, including those related to the timing, strategic benefits, financial benefits, and integration of the combined businesses.
• The filing refers to other SEC documents, including Strive's Form S-4 filed on December 3, 2025, and various 10-Q and 8-K reports from both companies, for additional information.

Sentiment

Score: 4

Explanation: The filing is a formal cautionary statement regarding a proposed merger, heavily emphasizing numerous risks and uncertainties, which creates a cautious sentiment despite the underlying strategic intent of the merger.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The future outlook for the proposed transaction is characterized by significant uncertainties and risks. While strategic and financial benefits are anticipated, there is no assurance that actual results will not differ materially from projections. The companies caution investors not to rely too heavily on forward-looking statements, as various factors could prevent the realization of expected outcomes, including challenges in integration, market conditions, and regulatory changes.

Management Comments

• The communication was reposted on X.com by Ben Werkman, Chief Investment Officer of Strive, Inc.

Industry Context

The filing highlights the increasing trend of companies, such as Strive, exploring or implementing Bitcoin treasury strategies, indicating a broader industry movement towards integrating digital assets into corporate financial management. The proposed merger itself reflects ongoing consolidation and strategic realignments within various sectors, aiming for synergistic benefits and market expansion.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of additional Class A common stock by Strive, and the requirement for Semler Scientific stockholders to approve the transaction.
• Customers: Potential adverse reactions or changes to business relationships.
• Employees: Potential changes to employee relationships.

Next Steps

• Strive will file a definitive Information Statement/Proxy Statement/Prospectus with the SEC.
• Semler Scientific stockholders will be sent the definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Keywords

Merger, Acquisition, Business Combination, SEC Filing, Strive Inc, Semler Scientific Inc, Forward-Looking Statements, Risk Factors, Bitcoin Treasury, Digital Assets, Corporate Governance